Fig S1. miR-10b overexpression in exosomes derived from MDA-MB-231 cells stably expressing miR-10b as compared to vector control exosomes. Supplementary.

Slides:

Advertisements

Similar presentations

Fig. 4-1, p Fig. 4-2, p. 109 Fig. 4-3, p. 110.

Advertisements

Slide 1Fig. 2.1a, p.25. Slide 2Fig. 2.1b, p.25 Slide 3Table 2.1, p.25.

Slide 1Fig. 22.1, p.669. Slide 2Fig. 22.3, p.670.

Slide 1Fig. 17.1, p.513. Slide 2Table 17.1, p.514.

Slide 1Fig. 11.1, p.337. Slide 2Fig. 11.2, p.338.

Slide 1Fig. 19.1, p Slide 2Fig. 19.2, p. 583.

Slide 1Fig. 21.1, p.641. Slide 2Fig. 21.2, p.642.

Slide 1Fig. 10.1, p.293. Slide 2Fig. 10.1a, p.293.

Slide 1Fig. 5.1, p.113. Slide 2Fig. 5.1a, p.113 Slide 3Fig. 5.1b, p.113.

P.464. Table 13-1, p.465 Fig. 13-1, p.466 Fig. 13-2, p.467.

Fig. 11-1, p p. 360 Fig. 11-2, p. 361 Fig. 11-3, p. 361.

Table 6-1, p Fig. 6-1, p. 162 p. 163 Fig. 6-2, p. 164.

Fig. 3-1, p. 67. Fig. 3-2, p. 67 Fig. 3-3, p. 68.

P Fig. 6-1, p. 193 Fig. 6-2, p. 193 Fig. 6-3, p. 195.

Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.

1 times table 2 times table 3 times table 4 times table 5 times table

Use Case 1: Exogenous exRNA in plasma of patients with Colorectal Cancer and Ulcerative Colitis Wednesday, Nov 5 th, :00 – 8:30 pm Organized and.

1-68M 1-6M X-29M 1-42M 1-9M NO MAR a b Supplemental Figure 1. GFP expression vectors, containing or not human MAR 1-68, 1-6, X-29, 1-9 or 1-42 (Girod et.

Last class Overall goal for labs 7-9 How to pick candidate miRNA targets Overview: “Validate” target prediction.

Transcriptional inhibiton of Hoxd4 expression by miRNA-10a in human breast cancer cells BMC Molecular Biology 2009, 10:12 doi: /

Xenograft TDDoxorubicinCisplatinIfosfamide SGDT/C%EfficacySGDT/C%EfficacySGDT/C%Efficacy OHS > CTPX > SBX6, >

Systems Biology and Genome Informatics of M. tuberculosis and other infectious diseases October 12-14, 2008 RUSSIA Molecular Players in Host-Pathogen Interaction:

A convenient system for highly specific and sensitive detection of miRNA expression Xiangqi Li, Minjie Ni, Chaobao Zhang, Wubin Ma, Yonglian Zhang SUPPLEMENTAL.

Head and Neck Cancer: microRNA analysis

Supplementary Table 1 – Details of clinical prostate samples used for miRNA microarray analysis. TURP: Transurethral resection of prostate, LRP: laparoscopic.

Introduction Results Conclusions Acknowledgements Alzheimer’s Disease (AD) is the most common chronic degenerative neurological disease, and there are.

AntibodyCatalog #Company Desminab15200Abcam Smooth muscle actinab5694Abcam S100ab868Abcam Cytokeration(AE1/AE3)ab961Abcam P53sc-6243Santa Cruz Calponinab46794Abcam.

Supplemental Table 1. Oligonucleotide sequences used for mRNA expression analysis by qPCR. Primer name Forward Primer 5’- 3’Reverse Primer 5’-3’ KLK3 5’-GTGCTTGTGGCCTCTCG-3’

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

Tables Learning Support

MiRNAs and their Applications Laura Martí Sánchez Genomics Advanced Genetic Master December, 2015.

Novel small RNAs expression libraries uncover hsa-mir30c and hsa-mir30b as key factors in anoikis resistance Miguel A. Moreno-Mateos*, Verónica Barragán*,

Stitching the Tutorials Together Introduction to Systems Biology Course Chris Plaisier Institute for Systems Biology.

MiRNAs and siRNAs 5 th March 2013 Saeideh Jafarinejad 4/22/2013 Rhumatology Research Center Lab(RRC lab)

Supplementary information Figure S1 Parental Mock ANXA1-V5 GAPDH MCF7-EV MCF7-V5 4 5 ANXA1 ANXA1-V5 Tubulin MCF7-parental MCF7-EV MCF7-V A B C ANXA1.

Wu et al., Supplementary Fig 1 Supplementary Figure 1: The depletion of BRG1 in HeLa cells has no effect on cell proliferation. Sh- empty vector was used.

Last class Overall goal for labs 7-9 How to pick candidate miRNA targets Overview: “Validate” target prediction.

Fig. 6-CO, p p. 185a p. 185b p. 185c p. 185d.

Pulmonary fibrosis cardiac fibrosis cardiovascular disease preeclampsia Hirschsprung’s disease rheumatoid arthritis systemic sclerosis systemic lupus erythematosus.

Fig. 4. miR-326, miR-330, and miR-3099 bound to the GFAP 3'-UTR and regulated GFAP expression. (A) Schematic diagram of potential binding sequence (seed.

Exosome-enclosed microRNAs in exhaled breath hold potential for biomarker discovery in patients with pulmonary diseases Anirban Sinha, MSc, Amit Kumar.

Dioufa et al. Supplemental Materials.

miRNAs regulated by c‐Myc in murine ES cells.

New research on the hypothalamic-pituitary-gonadal axis: H

a b p= 0,2 0,4 0,6 0,8 1 1,2 BCL11A * Relativeexpression 0,2 0,4 0,6

Supplemental table 3 miRNA shoot Root + - miRC

Supplementary Figure 1 A B C siControl siRNF31 siRNF31+siP53 siControl

Transfer of miR-223 during neutrophil-epithelial cell interactions

Supplementary Figure S1

NP23 leukemias exhibit Hox/Meis1 stem cell–like gene expression signatures that are enriched in human HSPC and AML genesets. NP23 leukemias exhibit Hox/Meis1.

MiR‐199a directly targets ERBB2 and ERBB3, whereas miR‐125b targets ERBB3. miR‐199a directly targets ERBB2 and ERBB3, whereas miR‐125b targets ERBB3. (A)

Supplementary Figure 2. Effect of IL-32 and siRNA of IL-32 on melanoma, colon and prostate cancer cell growth and apoptosis as well as IL-32 expression.

A B C E F D IC50 = 567 nM IC50 = 83 nM HAP1 WT HAP1 TOPK

MCF7z.p85WT MCF7z.p85S83μ MCF7z.p85S83A MCF7.vec MCF7z P-Akt T-Akt

Figure 2. ROC curves for different group comparisons

Fig. 3. miR-370 overexpression suppressed cell migration and invasion in HCC cells. (A) miR-370 expression in miR-370 overexpressed HCCLM3 cells were detected.

A B C D Alpha toxin PSMs 35kDa <10kDa PSMs <10kDa

Fig. 6-CO, p. 211.

Relative quantification of differentially expressed membrane proteins, distribution of coefficients of variation, and performance of the respiratory chain.A,

HDAC1 positively regulates the abundance of miRNAs.

Supplementary Fig. S1 BCL2 5’flanking ctrl siRNA luc

3 times tables.

6 times tables.

HOTAIR overexpression has marginal phenotypic and transcriptomic consequences on MDA‐MB‐231 HOTAIR overexpression has marginal phenotypic and transcriptomic.

Exosome-enclosed microRNAs in exhaled breath hold potential for biomarker discovery in patients with pulmonary diseases Anirban Sinha, MSc, Amit Kumar.

Overexpression of L1 in CRC cells induces NF-κB activation and suppression of p65 expression blocks the capacity to confer liver metastasis. Overexpression.

D-GM3 promotes uPAR clustering on the cell surface and activates p38 MAPK. A, uPAR expression in cells was either knocked down by treatment with 4 independent.

Presentation transcript:

Fig S1. miR-10b overexpression in exosomes derived from MDA-MB-231 cells stably expressing miR-10b as compared to vector control exosomes. Supplementary information Fig. S1 

miRNAFold changeSEM hsa-let-7a hsa-miR hsa-miR hsa-miR hsa-miR-29a hsa-miR hsa-let-7b hsa-miR hsa-miR-18a hsa-miR-23a hsa-miR-29b hsa-miR-34a hsa-let-7c hsa-miR hsa-miR-18b hsa-miR-23b hsa-miR-29c hsa-miR-34b hsa-let-7d hsa-miR-10a hsa-miR-19a hsa-miR hsa-miR-30a hsa-miR-34c-5p hsa-let-7e hsa-miR-10b hsa-miR-19b hsa-miR hsa-miR-30b hsa-miR-92a hsa-let-7f hsa-miR-15a hsa-miR-20a hsa-miR-26a hsa-miR-30c hsa-miR-92b hsa-let-7g hsa-miR-15b hsa-miR-20b hsa-miR-26b hsa-miR-30e hsa-miR hsa-let-7i hsa-miR hsa-miR hsa-miR-27b hsa-miR hsa-miR miRNAFold changeSEM hsa-miR-99a hsa-miR hsa-miR hsa-miR hsa-miR-106a hsa-miR-106b hsa-miR hsa-miR hsa-miR hsa-miR-125a-5p hsa-miR-125b hsa-miR hsa-miR-126* hsa-miR-127-5p hsa-miR hsa-miR-129-5p0.48 hsa-miR-130a hsa-miR-133a hsa-miR-133b hsa-miR hsa-miR-135a hsa-miR-135b hsa-miR hsa-miR hsa-miR hsa-miR-140-5p hsa-miR hsa-miR-142-5p hsa-miR-142-3p hsa-miR hsa-miR hsa-miR hsa-miR-146a hsa-miR-146b-5p hsa-miR-148a hsa-miR-148b hsa-miR hsa-miR hsa-miR-151-5p hsa-miR hsa-miR hsa-miR hsa-miR-181a hsa-miR-181b hsa-miR-181c hsa-miR-181d hsa-miR hsa-miR miRNAFold changeSEM hsa-miR hsa-miR hsa-miR hsa-miR-188-5p hsa-miR hsa-miR hsa-miR hsa-miR-193a-5p hsa-miR-193b hsa-miR hsa-miR hsa-miR-196a hsa-miR-196b hsa-miR-199a-5p hsa-miR-199a-3p hsa-miR-199b-5p hsa-miR-200a hsa-miR-200b hsa-miR-200c hsa-miR hsa-miR hsa-miR hsa-miR hsa-miR hsa-miR hsa-miR hsa-miR hsa-miR hsa-miR-216a hsa-miR hsa-miR-219-5p hsa-miR-220a hsa-miR hsa-miR hsa-miR hsa-miR hsa-miR hsa-miR-296-5p hsa-miR-301a hsa-miR hsa-miR-342-5p hsa-miR hsa-miR hsa-miR hsa-miR hsa-miR-376a 0.00 hsa-miR hsa-miR Table S1.Endogenous level of miRNA expression in MDA-MB-231 cells as compared to HMLE cells

Table S2. Secretory miRNA expression in MDA-MB-231 supernatant as compared to HMLE supernatant miRNAFold changeSEM hsa-let-7a hsa-miR hsa-miR hsa-miR hsa-miR-29a hsa-miR hsa-let-7b hsa-miR hsa-miR-18a hsa-miR-23a hsa-miR-29b hsa-miR-34a hsa-let-7c hsa-miR hsa-miR-18b hsa-miR-23b hsa-miR-29c hsa-miR-34b hsa-let-7d hsa-miR-10a hsa-miR-19a hsa-miR hsa-miR-30a hsa-miR-34c-5p hsa-let-7e hsa-miR-10b hsa-miR-19b hsa-miR hsa-miR-30b hsa-miR-92a hsa-let-7f hsa-miR-15a hsa-miR-20a hsa-miR-26a hsa-miR-30c hsa-miR-92b hsa-let-7g hsa-miR-15b hsa-miR-20b hsa-miR-26b hsa-miR-30e hsa-miR hsa-let-7i hsa-miR hsa-miR hsa-miR-27b hsa-miR hsa-miR miRNAFold changeSEM hsa-miR-99a hsa-miR hsa-miR hsa-miR hsa-miR-106a hsa-miR-106b hsa-miR hsa-miR hsa-miR hsa-miR-125a-5p hsa-miR-125b hsa-miR hsa-miR-126* hsa-miR-127-5p hsa-miR hsa-miR-129-5p hsa-miR-130a hsa-miR-133a hsa-miR-133b0.50 hsa-miR hsa-miR-135a hsa-miR-135b hsa-miR hsa-miR hsa-miR hsa-miR-140-5p hsa-miR hsa-miR-142-5p hsa-miR-142-3p hsa-miR hsa-miR hsa-miR hsa-miR-146a 1.10 hsa-miR-146b-5p 0.00 hsa-miR-148a hsa-miR-148b hsa-miR hsa-miR hsa-miR-151-5p hsa-miR hsa-miR hsa-miR hsa-miR-181a hsa-miR-181b hsa-miR-181c hsa-miR-181d hsa-miR hsa-miR Fold changeSEM hsa-miR hsa-miR hsa-miR hsa-miR-188-5p hsa-miR hsa-miR hsa-miR hsa-miR-193a-5p hsa-miR-193b hsa-miR hsa-miR hsa-miR-196a hsa-miR-196b hsa-miR-199a-5p hsa-miR-199a-3p hsa-miR-199b-5p0.28 hsa-miR-200a hsa-miR-200b hsa-miR-200c hsa-miR hsa-miR hsa-miR hsa-miR hsa-miR hsa-miR hsa-miR hsa-miR hsa-miR hsa-miR-216a hsa-miR hsa-miR-219-5p 0.28 hsa-miR-220a hsa-miR hsa-miR hsa-miR hsa-miR hsa-miR hsa-miR-296-5p hsa-miR-301a hsa-miR hsa-miR-342-5p hsa-miR hsa-miR hsa-miR hsa-miR hsa-miR-376a hsa-miR hsa-miR